GSK3B and colorectal carcinoma: Increased Fe2+ levels resulting from the high expression of STEAP3 inhibited glycogen synthase kinase-3 beta (GSK3β) activity by increasing the Ser9 phosphorylation of GSK3β, thereby activating Wnt signaling to support CRC progression [120].